CAG
LMAT icon

Cypress Advisory Group’s LeMaitre Vascular LMAT Stock Holding History

Cypress Advisory Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Hold
2,933
– – 0.22% 76
2026
Q1 		$320K Buy
+2,933
New +$280K 0.24% 70

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cypress Advisory Group's LMAT Position: Q2 2026 in Review

Cypress Advisory Group held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 2,933 shares worth $281K. The position accounts for 0.22% of the portfolio, ranked #76.

Cypress Advisory Group first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $320K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Cypress Advisory Group held 2,933 shares of LeMaitre Vascular worth $281K as of Q2 2026.
  • Cypress Advisory Group left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up 0.22% of Cypress Advisory Group's portfolio in Q2 2026, its #76 holding.
  • Cypress Advisory Group first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Cypress Advisory Group's LeMaitre Vascular position peaked at $320K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Cypress Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.